SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsArchive2026-11-05

Thu, Nov 05, 2026 - Page 152

18132 indexed SquawkNews stories from this UTC day. Showing 18121-18130.

EQUITY 11160EARNINGS 3842MACRO 558REGULATION 371CENTRAL_BANK 349NEWS 341MNA 283GEOPOLITICS 247RATES 237ENERGY 235COMMODITIES 219FX 177
L MKS Incorporated Reports Quarterly Results for Quarter Ended September 30 EQUITY | Nov 05, 2026, 12:00 AM UTC L Itafos Says Higher Sulfur Costs Drove Q3 2026 Net Income Decline EARNINGS | Nov 05, 2026, 12:00 AM UTC L Summit Therapeutics Reports Results for Quarter Ended September 30 EARNINGS | Nov 05, 2026, 12:00 AM UTC L Royal Gold Reports Results for Quarter Ended September 30 EARNINGS | Nov 05, 2026, 12:00 AM UTC L Lundin Gold Reports Third-Quarter 2026 Results EQUITY | Nov 05, 2026, 12:00 AM UTC L Lundin Gold Reports Q3 Adjusted EBITDA of USD 480.031 Million EARNINGS | Nov 05, 2026, 12:00 AM UTC L Lundin Gold Reports Q3 Free Cash Flow of USD 330.863 Million EQUITY | Nov 05, 2026, 12:00 AM UTC L Lundin Gold Reports Third-Quarter 2026 Results EQUITY | Nov 05, 2026, 12:00 AM UTC L Lundin Gold Reports Q3 Adjusted EPS of USD 1.23 EARNINGS | Nov 05, 2026, 12:00 AM UTC L HUTCHMED Says FDA Grants Sovleplenib Orphan Drug Designation The FDA granted orphan drug designation to HUTCHMED’s sovleplenib for autoimmune hemolytic anemia. REGULATION | Nov 05, 2026, 12:00 AM UTC